Deerfield Management and Optum Ventures, two investors, led a $75m round in Cortica, a physician-led autism services company, with participation from RA Capital Management, Echo Health Ventures, Longitude Capital, .406 Ventures, Questa Capital, Ajax Health, Aperture Venture Partners, and Autism Impact Fund. "We've been very impressed with Springtide's product and clinical quality. Our combination brings together two leaders in whole-child autism care and enables us to extend Cortica's medical model to Springtide's centers. We've also long admired the Melmed Center's research and clinical capabilities and are thrilled to welcome them into Cortica as our platform for growth in Arizona. We're honored to have Deerfield, Optum, RA, and Echo join our investor syndicate, which now includes five of the country's leading health plans. This represents an important validation of our clinical outcomes, payer cost savings, and custom technology platform Axon," Neil Hattangadi, Cortica Co-Founder and CEO.